Investor Relation

Providing outstanding service & high-quality, affordable generics Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products. MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Providing outstanding service & high-quality, affordable generics Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products. MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Providing outstanding service & high-quality, affordable generics Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products. MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Providing outstanding service & high-quality, affordable generics Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products. MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Providing outstanding service & high-quality, affordable generics Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products. MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team.